To detect whether liver immune disruptions after ApoA4 knockout in HFD-induced NAFL occurred during human NAFLD pathogenesis, we analyzed two microarray datasets (GSE151158 and GSE63067) from human liver tissue and the DEGs in whole hepatic immune cells from this study (Figure 6; Table S9). The gene discussed is APOA4; the disease is metabolic dysfunction-associated steatotic liver disease.